Robert Barrie
Publishes 1 feed
Pharmaceutical Technology
The leading site for news and procurement in the pharmaceutical industry
10 posts · contributor
Lately
Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’
Kynexis pockets €97m to advance cognition-focused schizophrenia drug
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
SandboxAQ introduces AQPotency for virtual drug screening
BioMarin spends up to $490m for Alesta’s bone disease candidate
Trump expected to nominate Heidi Overton as new FDA commissioner
Andelyn Biosciences to develop GM2 gangliosidosis therapy
BeOne Medicines and partners renew Brukinsa access programme for CLL
Reformed pharmaceutical regulation across India’s drug landscape
Updated UK guidance for finerenone introduces new treatment for HF patients
Everything on this page was read from markup Robert Barrie published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON